Chromosomal Instability Is Associated with cGAS–STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer
Cells · 2025
DOI: 10.3390/cells14060447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Kimio Yonesaka und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Chromosomal Instability, Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daiichi-Sankyo (Japan), Daiichi Sankyo Co., Ltd..
Abstract (Originalsprache)
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are standard therapies for EGFR-mutated non-small-cell lung cancer (NSCLC); however, their efficacy is inconsistent. Secondary mutations in the EGFR or other genes that lead to resistance have been identified, but resistance mechanisms have not been fully identified. Chromosomal instability (CIN) is a hallmark of cancer and results in genetic diversity. In this study, we demonstrated by transcriptomic analysis that CIN activates the cGAS–STING signaling pathway, which leads to EGFR-TKI refractoriness in a subset of EGFR-mutated NSCLC patients. Furthermore, EGFR-mutated H1975dnMCAK cells, which frequently underwent chromosomal mis-segregation, demonstrated refractoriness to the EGFR-TKI osimertinib compared to control cells. Second, H1975dnMCAK cells exhibited activation of cGAS–STING signaling and its downstream signaling, including tumor-promoting cytokine IL-6. Finally, chromosomally unstable EGFR-mutated NSCLC exhibited enhanced epithelial–mesenchymal transition (EMT). Blockade of cGAS–STING-TBK1 signaling reversed EMT, resulting in restored susceptibility to EGFR-TKIs in vitro and in vivo. These results suggest that CIN may lead to the activation of cGAS–STING signaling in some EGFR-mutated NSCLC, resulting in EMT-associated EGFR-TKI resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
- Department of Medical Oncology, Kishiwada City Hospital, Osaka 589-8511, Japan.
- Department of Pathology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
- Department of Immunology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
- Department of Genome Biology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
- Clinical Research Center, Kindai University Hospital, Osaka 589-8511, Japan.
ORCID-Profile: Hisato Kawakami, Shiki Takamura, Hiroki Goto, Kazuto Nishio, Kazuhiro Kakimi
Förderung
- Daiichi-Sankyo (Japan)
- Daiichi Sankyo Co., Ltd.
Zitieren
APA
Yonesaka, K., Kurosaki, T., Tanizaki, J., Kawakami, H., Tanaka, K., Maenishi, O., Takamura, S., Sakai, K., Chiba, Y., Teramura, T., Goto, H., Otsuka, E., Okida, H., Funabashi, M., Hashimoto, Y., Hirotani, K., Kamai, Y., Kagari, T., Nishio, K., …, & Hayashi, H. (2025). Chromosomal Instability Is Associated with cGAS–STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer. Cells. https://doi.org/10.3390/cells14060447
Vancouver
Yonesaka K, Kurosaki T, Tanizaki J, Kawakami H, Tanaka K, Maenishi O, et al. Chromosomal Instability Is Associated with cGAS–STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer. Cells. 2025. doi:10.3390/cells14060447
BibTeX
@article{Yonesaka2025,
author = {Yonesaka, Kimio and Kurosaki, Takashi and Tanizaki, Junko and Kawakami, Hisato and Tanaka, Kaoru and Maenishi, Osamu and Takamura, Shiki and Sakai, Kazuko and Chiba, Yasutaka and Teramura, Takeshi and Goto, Hiroki and Otsuka, Eri and Okida, Hiroaki and Funabashi, Masanori and Hashimoto, Yuuri and Hirotani, Kenji and Kamai, Yasuki and Kagari, Takashi and Nishio, Kazuto and Kakimi, Kazuhiro and Hayashi, Hidetoshi},
title = {Chromosomal Instability Is Associated with cGAS–STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14060447}
}
EUVIMED